Research. Innovation. Clarity. Results.

Neurolift provides comprehensive psychiatric care for a wide range of mental health conditions, including depression, anxiety disorders, bipolar disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), attention-deficit/hyperactivity disorder (ADHD), and other mood or thought-related conditions. Our team understands that each individual’s experience is unique, which is why we create personalized treatment plans designed to address your specific symptoms, goals, and lifestyle needs.

Transcranial Magnetic Stimulation (TMS) is an innovative, non-invasive, FDA-approved therapy for depression and other mood disorders. It works by delivering gentle, magnetic pulses to targeted regions of the brain responsible for mood regulation, particularly the prefrontal cortex. Unlike medications, TMS does not circulate through your bloodstream and therefore avoids many of the side effects often associated with antidepressants.
TMS sessions are performed in-office, typically lasting 20–40 minutes. Patients remain awake and alert throughout the procedure and can return to normal activities immediately afterward. Over the course of treatment, many patients experience significant improvement in mood, energy, and overall daily functioning.

Spravato® (esketamine) is a groundbreaking treatment option specifically designed for treatment-resistant depression (TRD) — when traditional antidepressants have not provided relief. Delivered as a nasal spray under medical supervision, Spravato® targets different neural pathways than standard medications, specifically acting on the glutamate system, which plays a critical role in mood regulation and neuroplasticity.
Patients often begin to notice improvements more rapidly than with traditional antidepressants, sometimes within hours or days. All Spravato® sessions at Neurolift are closely monitored in a safe, comfortable setting, ensuring both safety and effectiveness.